Brief: Cyxone Explores Orphan Drug Designation For Rabeximod

Cyxone AB

04/09/2019 13:52

Sept 4 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE EXPLORES ORPHAN DRUG DESIGNATION FOR RABEXIMOD
    * CYXONE IS NOW INITIATING EVALUATION OF POSSIBILITIES OF AN
ODD
FOR RABEXIMOD

Source text for Eikon:  ID:nWkrbyJKJm 
Further company coverage:  CYXO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))